Xylem Inc. (XYL) Analysts See $0.77 EPS

October 2, 2018 - By Ash

Xylem Inc. (NYSE:XYL) LogoInvestors sentiment increased to 1.01 in 2018 Q2. Its up 0.08, from 0.93 in 2018Q1. It increased, as 43 investors sold Xylem Inc. shares while 183 reduced holdings. 64 funds opened positions while 164 raised stakes. 147.62 million shares or 2.69% more from 143.75 million shares in 2018Q1 were reported.
Sei Invests invested in 85,811 shares. Oregon-based Baker Ellis Asset Ltd has invested 0.13% in Xylem Inc. (NYSE:XYL). Sumitomo Mitsui Asset Mgmt Com has invested 0.01% in Xylem Inc. (NYSE:XYL). Farmers And Merchants Invests Incorporated holds 3,467 shares. Ing Groep Nv stated it has 3,465 shares. Impax Asset Mgmt Ltd, a New Hampshire-based fund reported 150,700 shares. Scout Investments Incorporated invested 0.48% of its portfolio in Xylem Inc. (NYSE:XYL). 8,468 were reported by Atria Investments Ltd Llc. Nomura Asset Management Co has invested 0.02% of its portfolio in Xylem Inc. (NYSE:XYL). Cramer Rosenthal Mcglynn Limited Liability Company has 0.86% invested in Xylem Inc. (NYSE:XYL) for 713,352 shares. Aviva Pcl, United Kingdom-based fund reported 128,776 shares. Assetmark, California-based fund reported 742 shares. Contravisory Investment Inc stated it has 5,801 shares or 0.14% of all its holdings. Cushing Asset L P invested in 88,128 shares or 0.18% of the stock. Qci Asset Mgmt Ny holds 0% in Xylem Inc. (NYSE:XYL) or 70 shares.

Since May 14, 2018, it had 0 buys, and 4 selling transactions for $2.31 million activity. On Monday, September 17 Sabol Colin R sold $1.40 million worth of Xylem Inc. (NYSE:XYL) or 17,161 shares. Stellato Paul A had sold 3,000 shares worth $235,890 on Friday, September 7.

Analysts expect Xylem Inc. (NYSE:XYL) to report $0.77 EPS on October, 30.They anticipate $0.12 EPS change or 18.46 % from last quarter’s $0.65 EPS. XYL’s profit would be $138.30 million giving it 26.10 P/E if the $0.77 EPS is correct. After having $0.73 EPS previously, Xylem Inc.’s analysts see 5.48 % EPS growth. The stock decreased 0.31% or $0.25 during the last trading session, reaching $80.39. About 402,700 shares traded. Xylem Inc. (NYSE:XYL) has risen 27.16% since October 2, 2017 and is uptrending. It has outperformed by 11.54% the S&P500.

Xylem Inc. (NYSE:XYL) Ratings Coverage

Among 4 analysts covering Xylem (NYSE:XYL), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Xylem had 6 analyst reports since April 24, 2018 according to SRatingsIntel. On Wednesday, May 2 the stock rating was maintained by BMO Capital Markets with “Outperform”. The firm earned “Hold” rating on Wednesday, May 2 by Stifel Nicolaus. The firm earned “Outperform” rating on Wednesday, August 1 by BMO Capital Markets. On Wednesday, August 1 the stock rating was maintained by Stifel Nicolaus with “Hold”. The firm has “Hold” rating given on Tuesday, April 24 by Canaccord Genuity.

Xylem Inc. engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. The company has market cap of $14.44 billion. It operates through three divisions: Water Infrastructure, Applied Water, and Sensus. It has a 39.41 P/E ratio. The Water Infrastructure segment offers various products, including water and wastewater pumps, treatment and testing equipment, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, WEDECO, Godwin, WTW, Sanitaire, YSI, and Leopold names for the transportation, treatment, and testing of water and wastewater for public utilities and industrial applications.

Another recent and important Xylem Inc. (NYSE:XYL) news was published by Benzinga.com which published an article titled: “Raymond James: Water Is A Necessity, And So Is Xylem Stock” on September 05, 2018.

Xylem Inc. (NYSE:XYL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>